Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02832557 · ClinicalTrials.gov registry record
A Salivary miRNA Diagnostic Test for Autism
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 998
- Enrollment target
NCT02832557 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 998 participants.
The verdict
NCT02832557 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 998 participants
- Enrollment target
Study Summary
The goal of this study is to validate a panel of miRNAs that distinguish children with autism spectrum disorder (ASD) from their non-ASD peers with a positive MCHAT-R. These biomarkers may allow earlier diagnosis of autism, allowing earlier service, and also help us to understand some of the changes in the brains of autistic children.
Interventions
- OTHER Salivary collection
- OTHER Vineland Adaptive Behavior Scale-III Assessment
- OTHER Medical history questionaire
- OTHER Autism Diagnostic Observation Schedule -2nd edition (ADOS-2)
- OTHER Mullen Scales of Early Learning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 998 participants |
| Start Date | 2015-11-01 |
| Est. Completion | 2021-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02832557
The ClinicalTrials.gov registry entry for NCT02832557 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 998 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Salivary collection is the first listed.
NCT02832557 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02832557 about?
NCT02832557 is a clinical study titled "A Salivary miRNA Diagnostic Test for Autism". The goal of this study is to validate a panel of miRNAs that distinguish children with autism spectrum disorder (ASD) from their non-ASD peers with a positive MCHAT-R. These biomarkers may allow earlier diagnosis of autism, allowing earlier service, and also help us to understand some of the changes...
What is the current status of trial NCT02832557?
This trial is currently completed. The enrollment target is 998 participants. The study started on 2015-11-01. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT02832557?
The interventions under investigation include: Salivary collection (OTHER), Vineland Adaptive Behavior Scale-III Assessment (OTHER), Medical history questionaire (OTHER), Autism Diagnostic Observation Schedule -2nd edition (ADOS-2) (OTHER), Mullen Scales of Early Learning (OTHER).
Who is sponsoring clinical trial NCT02832557?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.